CCL18 and Alzheimer disease: At the same time, CCL3 (Koca et al., 2022), CCL15 (Marksteiner et al., 2011), CCL18 (Marksteiner et al., 2011), and IL-13 (Mohd Hasni et al., 2017) decreased in AD patients compared to controls.